William Plovanic: Okay. And then my last question is, you’ve really done a phenomenal job of kind of right-sizing the ship and getting it going again, and doing that in a very non-dilutive way thus far. And you’ve got about five quarters of cash. You’re burning — assuming the 15 million burn, these are my numbers not yours, but with the cash you have and that 50 million burn, that will be five, six quarters. Kind of how do you think about funding the company as you get work, because you’re exiting the year and into next year, even with a positive gross margin, you still need capital to execute? And so how are you thinking about that? And I don’t know if you’re ready to address that at this point in time, but I thought — to me that’s the elephant in the room that we’re looking at. Thanks for taking my questions.
David Roman: Yes, it’s a great question, Bill, and I may leave you a little unsatisfied in my response at this point of time, but let me give you a few thoughts that will help kind of contextualize how we’re approaching this. Firstly is our number one priority is to make the cash we have last as long as possible while not starving the business. We see ample opportunities, if needed, to evaluate our spin rate and cash burn and we will make necessary adjustments if we do need to respond to any unforeseen challenges in market dynamics. Second, we will receive the first earn-out from the distribution agreement with Medtronic obviously in the first half of next year. The measurement period is February to January then would expect to receive that royalty payment shortly after that.
Obviously that number is highly variable and depends on obviously the end user adoption of the Acutus product line and Medtronic’s commercialization which is thus far going very well. So we will look for any opportunity to maximize that earn-out to provide us further cushion with respect to our cash balance. Third is, as you know, we have a very strong partnership with Medtronic and BIOTRONIK. And as those companies continue to drive growth with our portfolio in key markets, that represents a source of both revenue and cash flow upside for us that may extend cash beyond what you are modeling. And then we will look to selectively consider different capital vehicles as we go through this year. Right now, our top, top priority is on driving the business.
And as we think about what the company will look like in early 2024 when we start to get closer to a point in time when a capital raise may be required, we believe we will have a very different profile than what you see today, a level of revenue scale and positive gross margin that becomes a much more attractive asset than what the company may look like on a trailing basis and will put us in a stronger position as possible to ensure we have the capital needed to run the business long term.
William Plovanic: Great. Thanks for taking my questions.
Operator: Thank you. That does conclude Acutus fourth quarter and full year earnings conference call. Thank you for participating. You may now disconnect.
